Artemesia BioMedical

Launched: 

2008

Sector: 

Artemesia BioMedical is the first biotechnology company to pioneer the development and commercialization of novel redesigned and repurposed artemisinin anti-malarial compounds for the treatment of cancer, inflammation and infectious diseases.

Team: 

Michael Kuran, Founder and CEO
Woerner Meehan, President